Archit Organosys logo

524640 - Archit Organosys Share Price

₹27.5 1.7  6.7%

Last Trade - 20/04/21

Basic Materials
Micro Cap
Market Cap £3.95m
Enterprise Value £6.64m
Revenue £7.71m
Position in Universe 2148th / 3108
Unlock 524640 Revenue
Relative Strength (%)
1m +17.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -2.48%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
555.4 513.5 484.9 817.1 840 766.9 +6.7%
+54.5 +46.4 -23.6 -76.0
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, ArchitOrganosys Ltd revenues increased 7% to RS640M. Net incometotaled RS34.2M vs. loss of RS2.9M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net Income reflectsFinance costs decrease of 9% to RS23.8M (expense), Otherexpenses decrease of 2% to RS74.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


524640 Revenue Unlock 524640 Revenue

Net Income

524640 Net Income Unlock 524640 Revenue

Normalised EPS

524640 Normalised EPS Unlock 524640 Revenue

PE Ratio Range

524640 PE Ratio Range Unlock 524640 Revenue

Dividend Yield Range

524640 Dividend Yield Range Unlock 524640 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
524640 EPS Forecasts Unlock 524640 Revenue
Profile Summary

Archit Organosys Limited is engaged in the business of dealing and manufacturing of chemicals. The Company's products include Mono Chloco Acetic Acid and Ethyle Acetate. The Company produces a range of organic chemicals, pigments, specialty derivatives, cosmetic products, adhesives and sealants. The Company's monochloroacetic acid and sodium monochloroacetate are used in the synthesis of various agricultural chemicals, cosmetic surfactants, oil drilling chemicals and plastic additives. The Company's Marval is a plant growth enhancer, which is made from organic plant waste. Marval contains natural trace elements, simple and complex sugars in a balanced form. Marval also contains phenolic compounds and cytokinins. The Auxins in Marval are naturally occurring plant growth hormones. The Company's coatings include AOL RUBBOCOAT and AOL ROOF & GUTTER SEALANTS. RubboCoat is a single component rapid drying paint. RubboCoat is used for vehicle underbody and roof tops.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated August 4, 1993
Public Since July 27, 1994
No. of Shareholders: n/a
No. of Employees: n/a
Sector Basic Materials
Industry Chemicals
Exchange Bombay Stock Exchange
Shares in Issue 15,020,700
Free Float (0.0%)
Eligible for
524640 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 524640
Upcoming Events for 524640
Wednesday 29th September, 2021 Estimate
Archit Organosys Ltd Annual Shareholders Meeting
Frequently Asked Questions for Archit Organosys
What is the Archit Organosys share price?

As of 20/04/21, shares in Archit Organosys are trading at ₹27.5, giving the company a market capitalisation of £3.95m. This share price information is delayed by 15 minutes.

How has the Archit Organosys share price performed this year?

Shares in Archit Organosys are currently trading at ₹27.5 and the price has moved by 0.366k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Archit Organosys price has moved by 0.201k% over the past year.

What are the analyst and broker recommendations for Archit Organosys?

There are no analysts currently covering Archit Organosys.

When will Archit Organosys next release its financial results?

Archit Organosys is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Archit Organosys dividend yield?

Archit Organosys does not currently pay a dividend.

Does Archit Organosys pay a dividend?

Archit Organosys does not currently pay a dividend.

When does Archit Organosys next pay dividends?

Archit Organosys does not currently pay a dividend.

How do I buy Archit Organosys shares?

To buy shares in Archit Organosys you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Archit Organosys?

Shares in Archit Organosys are currently trading at ₹27.5, giving the company a market capitalisation of £3.95m.

Where are Archit Organosys shares listed? Where are Archit Organosys shares listed?

Here are the trading details for Archit Organosys:

Country of listing: India
Exchange: BSE
Ticker Symbol: 524640
What kind of share is Archit Organosys?

Based on an overall assessment of its quality, value and momentum, Archit Organosys is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Archit Organosys share price forecast 2021?

We were not able to load any forecast data for Archit Organosys.

How can I tell whether the Archit Organosys share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Archit Organosys. Over the past six months, the relative strength of its shares against the market has been 41.29%. At the current price of ₹27.5, shares in Archit Organosys are trading at 55.66% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Archit Organosys PE Ratio?

The Archit Organosys PE ratio based on its reported earnings over the past 12 months is 14.26. The shares are currently trading at ₹27.5.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Archit Organosys?

Archit Organosys's management team is headed by:

Kandarp Amin - CHM
Archana Amin - EDR
Bhupendra Mehta - NID
Neeti Patel - SEC
Rajendraprasad Shah - IND
Archit Amin - EDR
Gajendrasingh Rajput - CFO
Anchal Bansal - CCO
Shreeraj Desai - IND
Who are the major shareholders of Archit Organosys?

Here are the top five shareholders of Archit Organosys based on the size of their shareholding:

Amin (Kandarp K) Individual Investor
Percentage owned: 24.44% (3.67m shares)
Amin (Archana K) Individual Investor
Percentage owned: 17.95% (2.70m shares)
Amin (Suchit K) Individual Investor
Percentage owned: 7.1% (1.07m shares)
Amin (Archit K) Individual Investor
Percentage owned: 5.63% (845k shares)
Patel (Sanjay kumar) Individual Investor
Percentage owned: 4.47% (671k shares)
Similar to 524640
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.